Skip to content
USA Classification Hub
NAICS 2022 nationalIndustry USA Verified: Census NAICS 2022 · 2026-01-01
325413

NAICS 325413 — In-Vitro Diagnostic Substance Manufacturing

In-Vitro Diagnostic Substance Manufacturing

NAICS 325413 is the national industry code for in-vitro diagnostic substance manufacturing establishments in the United States. The Small Business Administration sets a size standard of 1,250 for this classification. It forms part of the hierarchical North American Industry Classification System maintained by the Census Bureau.

SBA: 1,250 View full SBA standard

Related industries in 32541 (Pharmaceutical and Medicine Manufacturing)

View parent 32541

Official data

Feature Description
Official name North American Industry Classification System (NAICS) 2022
Issuing authority U.S. Census Bureau with OMB, Statistics Canada, and INEGI
Tax authority Internal Revenue Service (IRS)
Purpose Statistical business classification and federal contracting (SAM.gov, SBA standards)
Used in SAM.gov registration, SBA size determinations, IRS tax classification, SEC EDGAR (via SIC crosswalk)
Active since 2022 (current edition)
Hierarchy level Sector (2-digit)
Source https://www.census.gov/naics/

NAICS hierarchy path

Trace the classification from the broadest sector down to this national industry code.

Cross-references & crosswalks

NAICS 2017 equivalent 325413

In-Vitro Diagnostic Substance Manufacturing

View full 2022 → 2017 crosswalk
SBA size standard description

In‑Vitro Diagnostic Substance Manufacturing

Changes to receipts-based standard: [object Object]

Trade codes using this NAICS

These Schedule B export codes explicitly reference NAICS 325413 in the Census trade classification files.

Search this code across systems

Official resources